The transcription factor ZEB1 (δEF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarity

By Kirsten Aigner, B. Dampier, L. Descovich, M. Mikula, Aneesa Sultan, M. Schreiber, W. Mikulits, Thomas Brabletz, D. Strand, P. Obrist and 6 more. Oncogene, 2007

646 citations recorded by the source corpus.

Epithelial to mesenchymal transition (EMT) is implicated in the progression of primary tumours towards metastasis and is likely caused by a pathological activation of transcription factors regulating EMT in embryonic development. To analyse EMT-causing pathways in tumourigenesis, we identified transcriptional targets of the E-cadherin repressor ZEB1 in invasive human cancer cells. We show that ZEB1 repressed multiple key determinants of epithelial differentiation and cell–cell adhesion, including the cell polarity genes Crumbs3, HUGL2 and Pals1-associated tight junction protein. ZEB1 associated with their endogenous promoters in vivo, and strongly repressed promotor activities in reporter assays. ZEB1 downregulation in undifferentiated cancer cells by RNA interference was sufficient to upregulate expression of these cell polarity genes on the RNA and protein level, to re-establish epithelial features and to impair cell motility in vitro. In human colorectal cancer, ZEB1 expression was limited to the tumour–host interface and was accompanied by loss of intercellular adhesion and tumour cell invasion. In invasive ductal and lobular breast cancer, upregulation of ZEB1 was stringently coupled to cancer cell dedifferentiation. Our data show that ZEB1 represents a key player in pathologic EMTs associated with tumour progression.

Subfields: Cell Biology, Molecular Biology, Oncology

View Paper: https://www.semanticscholar.org/paper/e057954b22e77ab5f4e65126e5751beff078eb9f

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cell Biology

  1. R. Weinberg
  2. G. Moreno-Bueno
  3. A. Cano
  4. Yibin Kang
  5. Thomas Brabletz
  6. F. Portillo
  7. Simone Brabletz
  8. Jing Yang

In Molecular Biology

  1. R. Weinberg
  2. Thomas Brabletz
  3. Simone Brabletz
  4. M. Nieto
  5. Jing Yang
  6. Yibin Kang
  7. A. Cano
  8. Herbert Levine

In Oncology

  1. R. Weinberg
  2. Thomas Brabletz
  3. M. Nieto
  4. Simone Brabletz
  5. Jing Yang
  6. Yibin Kang
  7. A. Cano
  8. G. Moreno-Bueno

Citations in the corpus